Publication|Articles|August 6, 2023
- Pharmaceutical Executive: August 2023
- Volume 43
- Issue 8
Pharmaceutical Executive, August 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive August 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 3 years ago
Executive Roundtable: Innovations in Global Pharma Labelingalmost 3 years ago
A Fierce Focus On Unmet Needalmost 3 years ago
Pharma's ESG Equation: Materiality and Strategy are Keyalmost 3 years ago
Bridging the Divide: Medical's Omnichannel Momentumalmost 3 years ago
AI and Drug 'Re-Innovation'almost 3 years ago
More Evidence is Pointing to Potential Swing for Biotechalmost 3 years ago
2023 Proxy Season: Record Proposals, Sliding Supportalmost 3 years ago
Do Findings Point to a Tarnished COVID Victory for Europe?almost 3 years ago
Harnessing the Power of Communities to Combat Healthcare InequitiesAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How is Boehringer Ingelheim's Deliberate GLP-1 Strategy Different From Competitors?
2
Evolving Beyond Launch Postmortems to Real-Time Optimization
3
Expanding the Vaccine Landscape with New Technologies: Q&A with Silvia Taylor
4
Biogen Enters $1 Billion Agreement to Acquire RayThera Inc.
5

